News from the life sciences and technology communities north of Boston
|
|
|
Cummings is pleased to welcome CovalX to the life sciences community at 12 Gill Street, Woburn. Headquartered in Zürich, Switzerland with a subsidiary in Martillac, France, CovalX is a leader in protein interaction analytics by mass spectrometry. The company offers innovative technologies and a complete range of analytical services to its worldwide customer base. Ryan Wenzel, Ph.D., is vice chairman, director of North American Operations, and co-founder.
|
|
"Found" is a TechCrunch series featuring the stories behind the startups. Last month, program hosts were joined by Alex Rappaport, CEO and co-founder of ZwitterCo (12 Gill Street, Woburn), an innovative company that develops membrane technology to clean and recycle wastewater in industries like agriculture and bioprocessing. Tune in to hear Alex (pictured) talk about how his childhood on the Potomac River inspired his future career in clean water, and what it was like to build a commercial business off of existing lab research.
|
|
|
|
Akston Biosciences Corporation (100 Cummings Center, Beverly) has ended its vaccine partnership with Stelis Biopharma Limited and has reclaimed all commercial rights to AKS-452, its room temperature stable COVID-19 vaccine. Akston is continuing its progress to secure Emergency Use Authorization (EUA) in India and has begun working with a new CDMO to produce AKS-452. Read more.
|
|
Mediar Therapeutics Inc., a Cambridge-based biotechnology company advancing a portfolio of first-in-class therapies that halt and even reverse the course of fibrosis, today announced $105 million in funding. Mediar was founded on pioneering fibrosis research from Mass General and Brigham and Women's Hospitals in partnership with Mass General Brigham Ventures.
|
|
The venture arms of leading pharma companies are involved in the financing, which includes a recent $85 million Series A round co-led by Novartis Venture Fund and Sofinnova Partners and with participation from Pfizer Ventures, Mission BioCapital, Gimv, Pureos, Bristol Myers Squibb, Eli Lilly & Company, Ono Venture Investment, and Mass General Brigham Ventures. Read more in Endpoints News.
|
|
|
|
The 2023 application season is open for The Eddies, a seven-month program of Mass Innovation Network, offering an innovation support system to help early-stage startups (pre-Series C) take the next steps in their commercialization journey. The Eddies are open to New England-based startups (not exceeding 150 employees) with a working prototype of a ground-breaking product or technology. Read more, view deadlines, and apply.
|
|
34 Commerce Way, Woburn
30,000 SF Lab/R&D
|
|
This lab and manufacturing space is now available at the bustling Woburn life sciences hub. To learn more about this and other lab suites in greater Boston, contact John Halsey at 781-932-7039 or sales@cummings.com.
Suite features:
|
|
|
- 30,000 SF suite
- R&D, lab, and office areas
- High-capacity electrical services
|
|
- Significant HVAC and exhaust systems
- Potential for 19' high bay space
- Two loading docks
|
|
Campus neighbors include:
|
|
It was a great turnout for the MassBio Regional Mixer at Lord Hobo in Woburn in February.
|
|
Top photo (l to r): Bob Folger, account manager, Cummings Properties; Lauren Laidlaw, director, innovation & ecosystem activation, Bayer; and Josh Lang, associate director of business development, Asymchem. Top right photo: Al Diamond (left) business development director, Cummings Properties with Carter Swaebe of Cresa.
|
|
|
|
The next virtual BioXchange will be held Wednesday, March 29 from 4:00 to 7:00 PM. This free forum provides an opportunity to interact with individuals throughout the life sciences industry from all over the world. Register.
|
|
Against the backdrop of the evolving and unpredictable funding landscape, MassBio Align Summit connects investors with the brightest and best entrepreneurial startups and small companies in the life sciences. The day will include keynotes, panel discussions, and 20 pitches from innovative seed/series A biotech, healthtech, and medtech startups. Wednesday, April 26, 9:00 AM - 6:00 PM. Register.
|
|
|
Save the Date: North Shore Technology Council will host an evening of beer tasting and networking at Mission Boathouse in Beverly. The event brings together the NSTC biosciences, technology, and sustainability special interest groups. Thursday, May 18, 5:00 - 7:00 PM. The entrance cost is $10 for members and $25 for non-members, and includes two drink tickets and food. Register.
|
|
|
|
We welcome your feedback on this newsletter and invite readers to share company news, personnel changes, product launches, funding updates, events, and more. Contact Sue Howland, client engagement manager, at svh@cummings.com to offer your news for upcoming newsletters. We look forward to hearing from you.
|
|
|
|
|
|
|
